Oncopole

About Oncopole

Oncopole, the cancer hub of FRQ, is a research, development, and investment center aimed at accelerating cancer research in Quebec. Its mission is to act as a catalyst for actions within the oncology research and innovation ecosystem, positioning Quebec as a leader in the field. It focuses on research, entrepreneurship, the valorization and integration of innovation, and clinical relevance to mobilize stakeholders, discover innovative approaches to fight cancer, and ultimately benefit patients.

Products & Services

Funding Opportunities:Provides various funding opportunities for cancer research and innovation projects.

Funded Projects:Supports and showcases projects that have received funding for cancer research and care innovations.

Specialties

Oncology Research Cancer Care Innovation Precision Oncology Clinical Relevance Research and Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Strategic Investment T: - FT: Strategic Investment	A: 5000000 MR: - FA: Over $5 million FAN: 5000000	D: 2023-06-05 FD: 2023-06-05	3 investors

Strategic Investment Latest

2023-06-05

$5.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

Gaétan Barrette

Minister of Health and Social Services

R

Rémi Quirion

Chief Scientist of Quebec

C

Chirfi Guindo

President and Chief Executive Officer

M

Maxime Dumais

Development Coordinator

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

Oncopole Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised